what does glenmark pharmaceuticals do

Glenmark Pharmaceuticals Limited is a global research-led pharmaceutical company that develops, manufactures, and markets a wide range of generic, specialty, and over-the-counter (OTC) medicines and healthcare products across more than 80 countries worldwide.

what does glenmark clotrimazole do

Glenmark Clotrimazole is an antifungal medication used to treat fungal skin infections such as athlete's foot, jock itch, ringworm, and other related conditions by inhibiting the growth of fungi.

what does glenmark pharmaceuticals make

Glenmark Pharmaceuticals makes a diverse portfolio of products including generic formulations of leading branded medicines, specialty drugs for various therapeutic areas, and OTC products for common health issues, leveraging its global manufacturing and R&D capabilities.

what does glenmark adderall look like

Glenmark Adderall is a prescription medication available as capsules in various strengths, typically containing a white or off-white colored spherical or capsule-shaped solid dosage form with no visible coatings or markings, intended for oral use.

how does glenmark clotrimazole work

Glenmark Clotrimazole works by disrupting the cell membrane of fungi, leading to leakage of cellular contents and ultimately inhibiting their growth and survival, thereby treating fungal skin infections effectively.

Glenmark Pharmaceuticals Limited (GLENMARK) Share Price Today — ₹2,144.1

Glenmark Pharmaceuticals Limited (GLENMARK) live stock price is ₹2,144.1. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Glenmark Pharmaceuticals Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Glenmark Pharmaceuticals Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

GLENMARK

BSE

F&O

Glenmark Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE935A01035· Scrip: 532296

EN हिन्दी ગુજરાતી मराठी

₹2,144.10

▲ 63.15 (+0.00%)

2026-06-10

BSE

₹2,144.10

▲ 63.15

+0.00%

231 trading days · 1Y period

TODAY (BSE)

Open2,248.75

High2,251.00

Low2,137.05

Prev Close2,207.25

Volume39,029

Value₹8.6Cr

L: 2,137.05H: 2,251.00

Info

Face Value₹1

Listed2000-02-07

ISININE935A01035

SeriesA

BSE Scrip532296

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue-1.35%

PAT-1.82%

EPS-1.75%

Profitability

EBITDA Margin21.8%

Net Margin10.3%

TTM EBITDA M.39.1%

TTM Net M.-0.5%

Dividend

Yield—

Latest DPS₹2.5

Payout Ratio20.3%

Growth+0.00%

TTM Revenue

₹12214 Cr

TTM EBITDA

₹4771 Cr

TTM PAT

₹-58 Cr

TTM EPS

₹-2.22

Rev/Share

₹432.8

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	3388 Cr	2962 Cr	740 Cr	456 Cr	348 Cr	₹12.33
2024-09-30	3434 Cr	3001 Cr	759 Cr	473 Cr	354 Cr	₹12.55
2024-06-30	2330 Cr	1767 Cr	671 Cr	618 Cr	454 Cr	₹16.08
2024-03-31	3063 Cr	2859 Cr	2600 Cr	531 Cr	-1214 Cr	₹-43.18
2023-12-31	2507 Cr	2997 Cr	-312 Cr	-521 Cr	-331 Cr	₹-12.45
2023-09-30	3207 Cr	3008 Cr	195 Cr	-124 Cr	-64 Cr	₹-2.90
2023-03-31	3374 Cr	3025 Cr	-323 Cr	-491 Cr	-403 Cr	₹-15.18
2022-12-31	3464 Cr	3103 Cr	911 Cr	471 Cr	291 Cr	₹9.66

Shareholding Pattern

CURRENT — 2026-03-31

Promoter46.6%

FII20.3%

DII19.3%

Public53.4%

Govt0.0%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-10-03	Dividend	Interim Dividend - Rs 2.50 Per Share
2025-09-15	Dividend	Dividend - Rs 2.50 Per Share
2024-09-13	Dividend	Dividend - Rs 2.50 Per Share
2023-09-18	Dividend	Dividend - Rs 2.50 Per Share
2022-09-12	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-08	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2020-09-17	Dividend	Annual General Meeting/Dividend - Rs 2.50 Per Share
2019-09-19	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2018-09-19	Dividend	Annual General Meeting/Dividend Rs 2 Per Share
2017-09-20	Dividend	Annual General Meeting/Dividend - Rs 2/- Per Share
2016-08-03	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2015-09-10	Dividend	Annual General Meeting/ Dividend - Rs 2/- Per Share
2014-07-10	Dividend	Annual General Meeting / Dividend - Rs 2/- Per Share
2013-07-18	Dividend	Annual General Meeting / Dividend - Rs 2/- Per Share
2012-07-19	Dividend	Annual General Meeting / Dividend Rs 2 Per Share
2011-07-28	Dividend	Annual General Meeting And Dividend Re.0.40 Per Share
2010-09-16	Dividend	Annual General Meeting And Dividend Re.0.40 Per Share
2009-09-10	Other	Agm/Div-Re.0.40 Per Share
2008-09-18	Other	Annual General Meeting
2007-11-07	Dividend	Interim Dividend-70% Purpose Revised

Earnings Transcripts

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

9 Jun 2026NSE28K chars

Read →

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

29 May 2026NSE13K chars

Read →

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

14 Nov 2025NSE20K chars

Read →

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

14 Aug 2025NSE14K chars

Read →

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

23 May 2025NSE18K chars

Read →

Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation

14 Feb 2025NSE18K chars

Read →

Price History

Date	Open	High	Low	Close	Volume
2026-06-10	2,232.00	2,252.50	2,137.10	2,144.40	11.27L
2026-06-03	2,193.90	2,222.00	2,148.20	2,174.00	10.90L
2026-05-27	2,322.00	2,390.00	2,322.00	2,384.90	5.42L
2026-05-26	2,318.00	2,373.00	2,317.90	2,351.40	4.80L
2026-05-25	2,268.10	2,363.40	2,268.10	2,337.00	8.09L
2026-05-22	2,390.00	2,413.90	2,226.30	2,259.10	15.94L
2026-05-21	2,395.00	2,407.80	2,372.00	2,393.00	3.81L
2026-05-20	2,410.20	2,427.00	2,370.00	2,379.00	9.74L
2026-05-19	2,351.50	2,413.50	2,335.00	2,405.90	8.56L
2026-05-18	2,329.70	2,353.30	2,301.00	2,339.90	4.29L
2026-05-15	2,345.90	2,367.90	2,317.10	2,325.90	2.57L
2026-05-14	2,300.00	2,350.40	2,292.60	2,340.60	9.66L
2026-05-13	2,245.20	2,326.50	2,245.20	2,277.60	10.14L
2026-05-12	2,340.90	2,340.90	2,244.00	2,257.10	7.59L
2026-05-11	2,356.50	2,368.80	2,317.70	2,347.30	8.30L
2026-05-08	2,350.00	2,384.90	2,315.80	2,366.40	7.02L
2026-05-07	2,390.00	2,404.00	2,355.70	2,371.60	4.26L
2026-05-06	2,435.00	2,440.00	2,354.90	2,377.60	11.09L
2026-05-05	2,384.30	2,430.00	2,360.00	2,417.90	9.18L
2026-05-04	2,434.30	2,438.80	2,382.60	2,393.70	4.51L
2026-04-30	2,400.10	2,455.90	2,385.60	2,406.30	7.93L
2026-04-29	2,418.70	2,474.00	2,403.70	2,413.90	6.17L
2026-04-28	2,328.10	2,427.40	2,327.30	2,403.70	15.38L
2026-04-27	2,312.00	2,339.90	2,290.90	2,325.10	4.63L
2026-04-24	2,351.00	2,372.80	2,283.20	2,299.50	8.38L
2026-04-23	2,247.90	2,359.40	2,212.10	2,335.00	17.04L
2026-04-22	2,233.10	2,247.00	2,204.80	2,240.00	3.23L
2026-04-21	2,221.90	2,245.00	2,215.20	2,233.10	2.55L
2026-04-20	2,249.50	2,250.50	2,210.50	2,230.70	4.08L
2026-04-17	2,249.50	2,274.90	2,240.90	2,249.50	3.66L

Frequently Asked Questions

About

Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company headquartered in Mumbai, designs, manufactures, and markets a range of generic and specialty medicines, including active pharmaceutical ingredients (APIs) and formulations, serving both domestic and international markets. Key products include treatments for cardiovascular, central nervous system disorders, and oncology. Notably, the company was recognized as one of the "Best under a Billion Dollar Companies in Asia" by Forbes in 2008.